Related Experiment Video
Updated: Jan 9, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
Published on: March 30, 2018
Clinicopathologic Heterogeneity and Prognostic Determinants in Pediatric Chronic Active Epstein-Barr Virus Infection
Hao-Yue Jia1, Dong Wang2, Yun-Ze Zhao2
1Hematologic Disease Laboratory, Beijing Pediatric Research Institute; Beijing Children's Hospital, Capital Medical University; National Center for Children's Health; Key Laboratory of Major Diseases in Children, Ministry of Education; National Key Discipline of Pediatrics (Capital Medical University), Beijing, China.
Histopathologic grading of pediatric chronic active Epstein-Barr virus infection (CAEBV) is crucial for predicting outcomes. Multisite biopsies help in risk stratification and guiding therapy for this rare T/NK-cell lymphoproliferative disorder.
Area of Science:
- Hematology
- Oncology
- Virology
Background:
- Chronic active Epstein-Barr virus (CAEBV) infection is a rare, life-threatening lymphoproliferative disorder.
- It is driven by the Epstein-Barr virus and affects T/natural killer (NK) cells.
- CAEBV presents with diverse clinical and pathological features and lacks clear prognostic markers.
Purpose of the Study:
- To characterize the histopathologic spectrum of pediatric CAEBV.
- To evaluate the correlation between histopathologic features and clinical outcomes.
Main Methods:
- Retrospective analysis of 101 pediatric CAEBV patients.
- Assessment of clinical features, histopathologic grading (Grade-1, -2, -3), and immunophenotype.
- Evaluation of treatment responses and survival rates.
Main Results:
- Histopathologic grading revealed proliferative (52.5%), borderline (32.7%), and neoplastic (14.9%) lesions.
- Higher grades showed increased mixed T/NK-cell immunophenotypes and spatial heterogeneity.
- Pathologic grade significantly predicted treatment response and overall survival, while immunophenotype did not.
Conclusions:
- Histopathologic grading is a valuable prognostic tool for pediatric CAEBV.
- Multisite biopsies are essential for accurate risk stratification.
- Findings guide therapeutic strategies and improve patient outcomes.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism

